Amneal Pharmaceuticals Inc. Class A
News
LSV Asset Management Sells 8,300 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Zolmax LSV Asset Management trimmed its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 0.8% in the second quarter, according to its most recent Form 13F filing with the...\n more…
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Analysts
Ticker Report Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been given an average rating of "Moderate Buy" by the five ratings firms that are currently covering the company, MarketBeat.com...\n more…
Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Upgraded by JPMorgan Chase & Co.
Ticker Report Amneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) was upgraded by equities researchers at JPMorgan Chase Co. from an "underweight" rating to a "neutral" rating in a note issued to...\n more…
Allspring Global Investments Holdings LLC Decreases Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Ticker Report Allspring Global Investments Holdings LLC lessened its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 56.7% in the second quarter, Holdings Channel reports. The fund owned...\n more…
